HERSHEY, Dad. – dr. Yatin Vyas has been named chair of the Division of Pediatrics, Children’s Miracle Network and Four Diamonds Endowed Chair and pediatrician-in-chief at Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine, effective Nov. 1.
Previously, Vyas worked at the University of Iowa, where he was the Mary Joy and Jerre Stead Professor of Pediatrics, and led the Hematology/Oncology Division as Division Director since June 2013. During his time as director, Vyas led the Stead Family Children’s Hospital team to become a beacon of excellence for pediatric cancer care. In addition, he served on the executive leadership advisory committee of the National Cancer Institute-designated Holden Comprehensive Cancer Center and assistant director of the Physician-Scientist Training Pathway at Carver College of Medicine at the University of Iowa.
Prior to joining the University of Iowa, Vyas was a faculty member at UPMC’s Department of Pediatrics, Children’s Hospital of Pittsburgh, and Memorial Sloan-Kettering Cancer Center (MSKCC). He studied pediatrics at New York University Medical Center/Bellevue Hospital and completed a fellowship in pediatric hematology/oncology at MSKCC’s Memorial Hospital and New York-Presbyterian Hospital/Weill Cornell University Medical Center.
“I am so pleased that Dr. Vyas will bring his extensive knowledge and expertise to the College of Medicine,” said Dr. Kevin Black, Interim Dean. “His interest in scientific innovation and the delivery of advanced clinical care will benefit both students and our partner organizations, such as Children’s Miracle Network and Four Diamonds.”
Vyas holds certificates in physician leadership development in academic health centers from the Harvard School of Public Health and the University of Pittsburgh Katz School of Business. He recently graduated as a scientist in the Association of Medical School Pediatric Department Chairs Physician Leadership Development Program (AMSPDC-PLDP).
Vyas’s research is focused on determining the molecular cause and subsequent development of Wiskott-Aldrich syndrome (WAS), an inborn immune flaw. Research from his lab was essential to uncover for the first time an evolutionarily conserved, novel chromatin-resident role for WASp in gene transcription, genome stability and oncogenesis. His research has been funded almost continuously since 2002 by the National Institutes of Health (NIH). Vyas has served as a member of multiple NIH study sections and is an honorary member of the Society for Pediatric Research and American Pediatric Society.
Vyas replaces Dr. Michael Beck, who has been the department’s interim chair since February 2021 and will continue to serve as a faculty member.
Last updated September 29, 2021